1 Genetics Stock to Put on Your Radar
In the pharmaceutical space, there is clearly a lot of potential when it comes to genetics. In this Fool Live video clip, recorded on May 24, Fool.com healthcare and cannabis bureau chief Corinne Cardina, along with Fool.com contributor Brian Orelli, PhD, and chief growth officer Anand Chokkavelu, discuss why CRISPR Therapeutics (NASDAQ: CRSP) could be such an interesting opportunity for investors.
Source Fool.com


